Azmi Nabulsi
Dr. Nabulsi is COO of Phathom, a Frazier-founded company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. He is also an entrepreneur-in-residence on the life sciences team at Frazier Healthcare Ventures. Previously, he was the deputy chief medical and scientific officer and head of global development at Takeda Pharmaceuticals.
- October 2020
Added to: ReAlta Life Sciences Inc. - Norfolk, VA
ReAlta Life Sciences is an early-stage biotech company dedicated to harnessing the power of the immune system to address life-threatening medical needs. It has developed a novel class of drugs with unique multi-modal therapeutic capabilities that rebalance complement and inflammatory processes.